Health Condition 1: null- ASA I/II/III
Conditions
Interventions
Intervention1: Intravenous Pethidine, Butorphanol And Dexmedetomidine For Treatment Of Shivering Under Spinal Anaesthesia: The cases will be randomly divided into 3 groups (50 patients in eac
Sponsors
Bhagat Phool Singh Government Medical College For Women
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18-65 years( any gender) 2.American society of Anaesthesiologists (ASA) grade I , II &III physical status 3.Lower limb surgeries, inguinal, abdominal, urological and gynaecological procedures under spinal anaesthesia, who develop shivering during intra-operative and postoperative period (up to 2 hours) will be included in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with hypothyroidism or hyperthyroidism 2.Morbid Obesity (BMI > 40 kg/m2) 3.Fever (axillary temperature > 37 0 Celsius) 4.History of allergy to drugs. 5.Coagulation disorders 6.Patients with significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome will be to compare the efficacy and response rates of pethidine, butorphanol and dexmedetomidine.Timepoint: The time taken for cessation of shivering will be recorded at 1 minute interval till 5 min and thereafter upto 30 minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To monitor the vital parameters in all the three groups and compare them subsequently. 2.To record the incidence of recurrence in all the three groups. 3.To record and compare the incidence of adverse effects such as nausea, vomiting, sedation, etc. amongst the three groups. Timepoint: Maximum Upto Two Hours | — |
Countries
India
Contacts
Public ContactGarima Sharma
Bhagat Phool Singh Government Medical College For Women
Outcome results
None listed